Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in...

Area of Science:

• Cardiovascular Biology
• Molecular Signaling
• Endothelial Cell Function

Background:

• The Rho/Rho-kinase pathway is crucial in cardiovascular diseases like arteriosclerosis and hypertension.
• C-reactive protein (CRP), a cardiovascular event marker, exhibits proatherothrombotic effects on vascular cells.
• The precise molecular mechanisms underlying CRP's vascular effects require further investigation.

Purpose of the Study:

• To investigate the involvement of the Rho/Rho-kinase signaling pathway in C-reactive protein (CRP)-induced plasminogen activator inhibitor-1 (PAI-1) expression.
• To elucidate the molecular mechanisms by which CRP influences endothelial cell function and contributes to atherothrombogenesis.

Main Methods:

• Bovine aortic endothelial cells (BAECs) were treated with human recombinant CRP.
• PAI-1 expression was measured using Western blotting.
• RhoA activation was assessed via affinity pull-down assays.
• NF-kappaB activity was quantified using a luciferase reporter gene assay.
• Inhibitors of RhoA, Rho-kinase, and NF-kappaB were utilized to determine pathway involvement.

Main Results:

• CRP significantly increased PAI-1 expression and RhoA activation in BAECs.
• Inhibition of RhoA and Rho-kinase pathways attenuated CRP-induced PAI-1 expression.
• CRP markedly enhanced NF-kappaB activity, which was subsequently inhibited by Rho-kinase inhibition.
• NF-kappaB inhibitors effectively blocked CRP-mediated PAI-1 expression.

Conclusions:

• CRP activates the Rho/Rho-kinase signaling pathway in endothelial cells.
• This activation leads to enhanced NF-kappaB activity, resulting in increased PAI-1 expression.
• The Rho/Rho-kinase pathway is implicated in the atherothrombotic effects of CRP.